158 related articles for article (PubMed ID: 14523980)
1. Antisense imaging: and miles to go before we sleep?
Lewis MR; Jia F
J Cell Biochem; 2003 Oct; 90(3):464-72. PubMed ID: 14523980
[TBL] [Abstract][Full Text] [Related]
2. Early detection of chemoresistance in vivo through the use of a radiolabeled antisense oligonucleotide.
Touboul M; Gauchez AS; D'Hardemare Adu M; Lunardi J; Deverre JR; Pernin C; Mathieu JP; Vuillez JP; Fagret D
Anticancer Res; 2002; 22(6A):3349-56. PubMed ID: 12530086
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
[TBL] [Abstract][Full Text] [Related]
4. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
Mahato RI; Cheng K; Guntaka RV
Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
[TBL] [Abstract][Full Text] [Related]
5. Locked nucleic acid molecular beacons.
Wang L; Yang CJ; Medley CD; Benner SA; Tan W
J Am Chem Soc; 2005 Nov; 127(45):15664-5. PubMed ID: 16277483
[TBL] [Abstract][Full Text] [Related]
6. Imaging gene expression using oligonucleotides and peptide nucleic acids.
Paroo Z; Corey DR
J Cell Biochem; 2003 Oct; 90(3):437-42. PubMed ID: 14523977
[TBL] [Abstract][Full Text] [Related]
7. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of hybridization of mRNA of c-myc oncogene with 111In-labeled antisense oligodeoxynucleotide probes by high-pressure liquid chromatography.
Dewanjee MK; Ghafouripour AK; Kapadvanjwala M; Samy AT
Biotechniques; 1994 May; 16(5):844-6, 848, 850. PubMed ID: 8068339
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotide technology in the development of cancer therapeutics.
Tseng BY; Brown KD
Cancer Gene Ther; 1994 Mar; 1(1):65-71. PubMed ID: 7621240
[No Abstract] [Full Text] [Related]
10. Uptake kinetics of 99mTc-MAG3-antisense oligonucleotide to PCNA and effect on gene expression in vascular smooth muscle cells.
Zhang YR; Zhang YX; Cao W; Lan XL
J Nucl Med; 2005 Jun; 46(6):1052-8. PubMed ID: 15937319
[TBL] [Abstract][Full Text] [Related]
11. A novel integrated strategy (full length gene targeting) for mRNA accessible site tagging combined with microarray hybridization/RNase H cleavage to screen effective antisense oligonucleotides.
Sun Y; Duan M; Lin R; Wang D; Li C; Bo X; Wang S
Mol Vis; 2006 Nov; 12():1364-71. PubMed ID: 17149362
[TBL] [Abstract][Full Text] [Related]
12. A potential role for antisense oligonucleotide analogues in the development of oncogene targeted cancer chemotherapy.
Tidd DM
Anticancer Res; 1990; 10(5A):1169-82. PubMed ID: 2241097
[TBL] [Abstract][Full Text] [Related]
13. Molecular therapy of human neuroblastoma cells using Auger electrons of 111In-labeled N-myc antisense oligonucleotides.
Watanabe N; Sawai H; Ogihara-Umeda I; Tanada S; Kim EE; Yonekura Y; Sasaki Y
J Nucl Med; 2006 Oct; 47(10):1670-7. PubMed ID: 17015904
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells.
Aukunuru JV; Ayalasomayajula SP; Kompella UB
J Pharm Pharmacol; 2003 Sep; 55(9):1199-206. PubMed ID: 14604462
[TBL] [Abstract][Full Text] [Related]
15. Hybridization of antisense reagents to RNA.
Sohail M; Southern EM
Curr Opin Mol Ther; 2000 Jun; 2(3):264-71. PubMed ID: 11249620
[TBL] [Abstract][Full Text] [Related]
16. RNAi: a novel antisense technology and its therapeutic potential.
Dallas A; Vlassov AV
Med Sci Monit; 2006 Apr; 12(4):RA67-74. PubMed ID: 16572063
[TBL] [Abstract][Full Text] [Related]
17. Application of antisense oligonucleotides for gene functionalization and target validation.
Bennett CF; Cowsert LM
Curr Opin Mol Ther; 1999 Jun; 1(3):359-71. PubMed ID: 11713801
[TBL] [Abstract][Full Text] [Related]
18. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
19. LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.
Vester B; Wengel J
Biochemistry; 2004 Oct; 43(42):13233-41. PubMed ID: 15491130
[TBL] [Abstract][Full Text] [Related]
20. Linear RNA amplification for the production of microarray hybridization probes.
Klebes A; Kornberg TB
Methods Mol Biol; 2008; 420():303-17. PubMed ID: 18641956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
